Rifaximin in the treatment of hepatic encephalopathy. - Wikidata - wikimedia - TriplyDB

Rifaximin in the treatment of hepatic encephalopathy.

Rifaximin in the treatment of hepatic encephalopathy.

http://www.wikidata.org/entity/Q37355818

about

Management options in decompensated cirrhosis Rifaximin: a review of its use in reducing recurrence of overt hepatic encephalopathy episodes.Perioperative management of liver surgery-review on pathophysiology of liver disease and liver failure.

P2860

Q26800238-0CBC805B-61A1-4F52-8B47-2469D736C34B Q35373588-6C2BCE01-22C8-4885-BAC9-E04E8F59004F Q54957946-D901CD20-D19F-47ED-B7B4-096B8211DABC

P2860

Rifaximin in the treatment of hepatic encephalopathy.

http://www.wikidata.org/entity/Q37355818

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 December 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Rifaximin in the treatment of hepatic encephalopathy.

@en

Rifaximin in the treatment of hepatic encephalopathy.

@nl

type

label

Rifaximin in the treatment of hepatic encephalopathy.

@en

Rifaximin in the treatment of hepatic encephalopathy.

@nl

prefLabel

Rifaximin in the treatment of hepatic encephalopathy.

@en

Rifaximin in the treatment of hepatic encephalopathy.

@nl

P1433

Q37355818-CEC4D613-D0E5-453A-BE5D-AD14926E49C6

P1476

Q37355818-43C640AB-353A-46BF-98EF-5529D023A2EC

P2093

Q37355818-298BB710-2B82-45C9-BA98-CF7D2E7CDFFF

Q37355818-7B6149E7-170E-496D-BEC9-6124DFAC6A21

Q37355818-84ACB058-F93C-4CDA-81A8-1E35ADE36005

Q37355818-B0764A11-D96C-494F-9D44-C884722A43CC

Q37355818-DCFA130E-5E20-4470-80E9-657FEA7DDBE6

P2860

Q37355818-05218D4E-E0B1-4698-9C51-299EC928BBC4

Q37355818-0FBEBB00-F357-4778-AE4B-8672745BE167

Q37355818-117046DD-4BE1-443C-B60C-D7FC2CD12070

Q37355818-13D90DE3-EE45-4092-BD59-0E9196689A9B

Q37355818-13EFED59-6272-4903-B38B-45AAB57B9FE9

Q37355818-1634B413-54C5-435D-AB87-0FD805ACD3B5

Q37355818-188B4D79-2371-433F-8911-5A161CA6C5B8

Q37355818-1BC78739-03E6-4566-9089-4323C498F7BD

Q37355818-1CE636CB-B2F9-41E5-9473-EFA14D6E1866

Q37355818-1D7FF0AA-5841-49AB-82E6-647FE1030CEF

P304

Q37355818-C1BA460A-B43F-4226-ACD0-7FFD7C2AD105

P31

Q37355818-A9FCABA8-137D-4936-BCAC-EAC67776BFAE

P356

Q37355818-6BA94DAF-729F-4BF2-A51D-BE1058D68EDA

P478

Q37355818-02996B23-9786-4D48-9178-0D7851E86D32

P50

Q37355818-9F8FFE5F-EDF3-4037-8B54-B7CA38DFAEF9

P577

Q37355818-84AD3025-1A8C-4B01-806F-A7499F04BB83

P5875

Q37355818-050D931B-902C-49EB-9943-A78382BBD7FB

P698

Q37355818-90C54349-1069-4387-953F-63CEF6117BAE

P932

Q37355818-CAE85EB4-5146-4BBD-BAF6-2540F714D0D0

P356

P1433

Hepatic Medicine: Evidence and Research

P1476

Rifaximin in the treatment of hepatic encephalopathy.

@en

P2093

Anna Del Prete

http://www.w3.org/2001/XMLSchema#string

Carmelina Loguercio

http://www.w3.org/2001/XMLSchema#string

Claudia Cesaro

http://www.w3.org/2001/XMLSchema#string

Laura Gaeta

http://www.w3.org/2001/XMLSchema#string

Maddalena Diana Iadevaia

http://www.w3.org/2001/XMLSchema#string

P2860

Rifaximin treatment in hepatic encephalopathy

National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data.

MR imaging findings in hepatic encephalopathy.

Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.

Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study.

Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy.

Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study.

Factors associated with poor health-related quality of life of patients with cirrhosis.

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Resistance to antibiotics mediated by target alterations.

P304

109-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/HMER.S11988

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259456508

http://www.w3.org/2001/XMLSchema#string

P698

24367227

http://www.w3.org/2001/XMLSchema#string

P932

3846583

http://www.w3.org/2001/XMLSchema#string